Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT04506554 |
| Title | A Study of Risk Enabled Therapy After Neoadjuvant Immunochemotherapy for Bladder Cancer |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | Fox Chase Cancer Center |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| UNC Lineberger Comprehensive Cancer Center | Chapel Hill | North Carolina | 27599 | United States | Details | |
| Thomas Jefferson University Hospital | Philadelphia | Pennsylvania | 19107 | United States | Details | |
| Fox Chase Cancer Center - Philadelphia | Philadelphia | Pennsylvania | 19111-2497 | United States | Details | |
| UT Southwestern Medical Center | Dallas | Texas | 75390 | United States | Details |